SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks
Pharmos(PARS)
An SI Board Since November 1996
Posts SubjectMarks Bans Symbol
1491 8 0 PARS
Emcee:  Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
741 QUOTE from Briefing.com>>> 10:00 ET VidaMed (VIDA) 4 1/8 +9/16 (+16%)johnny weissman-5/6/1998
740 Not so fast David: Here's what management had to say in the Annual Report- arnie h-5/6/1998
739 Gabe, don't look at share price when evaluating biotechs. You need to lookwolfdog2-5/6/1998
738 david remember the rest of the world when u look at numbers Gabe Fernandez-5/6/1998
737 Thought STORZ detailed surgical instrumentation Gabe Fernandez-5/6/1998
736 regardless of the number--the longer we live the more need for cataract surgeryGabe Fernandez-5/6/1998
735 Yosi we should also consider that BOL bought a group of Eye surgical centers anGabe Fernandez-5/6/1998
734 Lady you have a misconception of surgeons . It is very important for them and tGabe Fernandez-5/6/1998
733 a 50% improvement in the mortality rate is outstanding but also an improvement Gabe Fernandez-5/6/1998
732 Ms. GINA KOLATA is the NY times reporter and Dr. Yosi is the most QUALIFIED MDDavid Israel-Rosen-5/5/1998
731 Hello: If Merav read the report in the NY Times she can call them by phone (mDavid Israel-Rosen-5/5/1998
730 Doesn't anyone know a writer for the Science page at the NY Times? If so, David W-5/5/1998
729 a Pharmos posting in today's globes globes.co.ilDavid Israel-Rosen-5/5/1998
728 I guess biotech are down today after yesterdays "exsuberance"yosi s-5/5/1998
727 Rudeness to any sincere poster is uncalled for. There is always a crowd on any johnny weissman-5/5/1998
726 Merav: I need time to digest this. will get back to you soonDavid Israel-Rosen-5/5/1998
725 "Pharmos cancer drug is as good as Entremed's" Well that is theyosi s-5/5/1998
724 Pharmos cancer drug is as good as Entremed's, I'm surprised nobody has Merav-5/5/1998
723 Omer I agree with you post. But let me clarify my understanding of dosing and yosi s-5/5/1998
722 PARS will probably release results for the first two groups sometime this summeOmer Shvili-5/5/1998
721 yosi, Thanks for the interpretation. You mentioned that the Group two study wStephen D. Wilson-5/5/1998
720 What else is new ?David Israel-Rosen-5/4/1998
719 I guess Yosi was right and Investor Lady was wrong. David W-5/4/1998
718 Glad to see neurosurgeon on the thread. did you get a chance to see PARS web pyosi s-5/4/1998
717 Sorry about the jargon Cohort= group. in phase 2 study of hu211 there are nowyosi s-5/4/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News